Helminth infection reactivates latent γ-herpesvirus via cytokine competition at a viral promoter
T. A. Reese , B. S. Wakeman , H. S. Choi , M. M. Hufford
Science 345 ( 6196) 573 -577
126
2014
Influenza-Infected Neutrophils within the Infected Lungs Act as
MM Hufford , G Richardson , H Zhou , B Manicassamy
2012
Rapid and Sustained Improvements in both Skin and Musculoskeletal Symptoms Correlates with Improved Quality of Life (QoL) in Patients with Active Psoriatic Arthritis (PSA)
A Kavanaugh , J Birt , CY Lin , O Benichou
36 ( 4) 755 -755
2018
Serum interleukin (IL)-9 and IL-10, but not T-helper 9 (Th9) cells, are associated with survival of patients with acute-on-chronic hepatitis B liver failure.
Sabry A Sabry , Fardous F. El-Senduny , Nashwa K. Abousamra , Manal Salah EL-Din
American Journal of Biochemistry and Molecular Biology 8 ( 1) 3039 -3047
2014
Withdrawing Ixekizumab in Patients with Psoriatic Arthritis who Achieved Minimal Disease Activity: Results from a Randomized, Double-Blind Withdrawal Study.
Laura C Coates , Sreekumar G Pillai , Hasan Tahir , Ivo Valter
Arthritis & Rheumatism
1
2021
Neutralizing monoclonal antibodies for treatment of COVID-19.
Kevin Winthrop , Peter C Taylor , Andrew C Adams , Inmaculada de la Torre
Nature Reviews Immunology 21 ( 6) 1 -12
489
2021
Recent insights into pulmonary repair following virus-induced inflammation of the respiratory tract.
Stacey A Gorski , Matthew M Hufford , Thomas J Braciale
Current Opinion in Virology 2 ( 3) 233 -241
21
2012
A gut reaction to IL-9
Matthew M Hufford , Mark H Kaplan
Nature Immunology 15 ( 7) 599 -600
10
2014
The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic arthritis: a post hoc analysis of two randomised controlled studies.
Arthur Kavanaugh , Alice Gottlieb , Akimichi Morita , Joseph F Merola
Annals of the Rheumatic Diseases 78 ( 9) 1215 -1219
10
2019
Bebtelovimab, alone or together with bamlanivimab and etesevimab, as a broadly neutralizing monoclonal antibody treatment for mild to moderate, ambulatory COVID-19
Michael Dougan , Masoud Azizad , Peter Chen , Barry Feldman
MedRxiv 2022 -03
35
2022
ERG functionally overlaps with other Ets proteins in promoting TH9 cell expression of Il9 during allergic lung inflammation
Rakshin Kharwadkar , Benjamin J Ulrich , Michelle Chu , Byunghee Koh
The Journal of Immunology 210 ( 5) 537 -546
4
2023
Novel methodology comparing two assay formats for the assessment of immunogenicity from clinical trial samples
Daniel A Peterson , Thomas G Pottanat , Heather Denning , Nicoletta Bivi
Bioanalysis 13 ( 14) 1113 -1121
2021
Pharmacokinetics, efficacy, and safety of a SARS-CoV-2 antibody treatment in pediatric participants: an open-label addendum of a placebo-controlled, randomized phase 2/3 trial
Himanshu P Upadhyaya , Jenny Y Chien , Amanda J Long , Martin S Bohm
Infectious Diseases and Therapy 12 ( 7) 1861 -1873
1
2023
Withdrawal of Ixekizumab Results in Loss of Efficacy in Multiple Clinical Domains in Patients with Psoriatic Arthritis Who Had Achieved Minimal Disease Activity: Results from the SPIRIT-P3 Study
Laura Coates , Sreekumar Pillai , Matthew M Hufford , Denise Alves
ARTHRITIS & RHEUMATOLOGY 71
1
2019
Resolution of enthesitis and dactylitis is maintained over two years of ixekizumab treatment in patients with psoriatic arthritis
Arthur Kavanaugh , Lihi Eder , Josef Smolen , Matthew M Hufford
ARTHRITIS & RHEUMATOLOGY 71
5
2019
Safety Profile of Ixekizumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis and Psoriatic Arthritis: Integrated Analysis of 18 Clinical Trials
Mark Genovese , Hideto Kameda , Proton Rahman , Juan Canete
ARTHRITIS & RHEUMATOLOGY 71
1
2019
Bamlanivimab and Etesevimab Improve Symptoms and Associated Outcomes in Ambulatory Patients at Increased Risk for Severe Coronavirus Disease 2019: Results From the Placebo-Controlled Double-Blind Phase 3 BLAZE-1 Trial
Peter Chen , Gerhard Behre , Corey Hebert , Princy Kumar
Open Forum Infectious Diseases 9 ( 5) ofac172 -ofac172
5
2022
The effector T cell response to influenza infection
Matthew M Hufford , Taeg S Kim , Jie Sun , Thomas J Braciale
Influenza Pathogenesis and Control-Volume II 423 -455
118
2015
Th 9 Cells: From the Bench to the Bedside and Back Again
Benjamin J Ulrich , Matthew M Hufford , Mark H Kaplan
Inflammation: From Molecular and Cellular Mechanisms to the Clinic 365 -394
2017
Influenza-Infected Neutrophils within the Infected Lungs Act as Antigen Presenting Cells for Anti-Viral CD8+ T Cells
Matthew M Hufford , Graham Richardson , Haixia Zhou , Balaji Manicassamy
PLoS ONE 7 ( 10) e46581
80
2012